Add to ORKGA single-center study on predicting outcomes of primary androgen deprivation therapy for prostate cancer using the Japan Cance
Objectives To compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in J...
ObjectivesTo compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in Ja...
BackgroundThe University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment ...
Background: A novel risk assessment method, Japan Cancer of the Prostate Risk Assessment, has been d...
BACKGROUND: A novel risk assessment method, Japan Cancer of the Prostate Risk Assessment, has been d...
PurposeTo determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy wi...
To determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy with an l...
PurposeProstate cancer epidemiology has been marked overall by a downward risk migration over time. ...
Background: Based on the data of current status of endocrine therapy for prostate cancer registered ...
This report summarizes the presentations and discussions that took place at the Seventh Joint Meetin...
This report summarizes the presentations and discussions that took place at the Fifth Joint Meeting ...
Purpose: To determine if there is a correlation between the newly proposed Gleason grading system by...
This report summarizes the presentations and discussions that took place at the Seventh Joint Meetin...
BackgroundThe authors previously developed and validated the Cancer of the Prostate Risk Assessment ...
This report summarizes the presentations and discussions that took place at the Sixth Joint Meeting ...
Objectives To compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in J...
ObjectivesTo compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in Ja...
BackgroundThe University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment ...
Background: A novel risk assessment method, Japan Cancer of the Prostate Risk Assessment, has been d...
BACKGROUND: A novel risk assessment method, Japan Cancer of the Prostate Risk Assessment, has been d...
PurposeTo determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy wi...
To determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy with an l...
PurposeProstate cancer epidemiology has been marked overall by a downward risk migration over time. ...
Background: Based on the data of current status of endocrine therapy for prostate cancer registered ...
This report summarizes the presentations and discussions that took place at the Seventh Joint Meetin...
This report summarizes the presentations and discussions that took place at the Fifth Joint Meeting ...
Purpose: To determine if there is a correlation between the newly proposed Gleason grading system by...
This report summarizes the presentations and discussions that took place at the Seventh Joint Meetin...
BackgroundThe authors previously developed and validated the Cancer of the Prostate Risk Assessment ...
This report summarizes the presentations and discussions that took place at the Sixth Joint Meeting ...
Objectives To compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in J...
ObjectivesTo compare directly survival outcomes of primary androgen-deprivation therapy (PADT) in Ja...
BackgroundThe University of California, San Francisco (UCSF) Cancer of the Prostate Risk Assessment ...